Quick Answer
IMPACT BIOMEDICAL INC. reported Stockholders Equity of $12.61 million for fiscal year 2025.
IMPACT BIOMEDICAL INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $12.61M | +196.1% |
| 2024 | $4.26M | -83.1% |
| 2023 | $25.22M | -14.7% |
| 2022 | $29.56M | -26.0% |
| 2021 | $39.92M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$11.81M | -137.7% | -14.2% |
| June 30, 2025 | -$10.34M | -144.2% | -369.1% |
| March 31, 2025 | $3.84M | -84.2% | -9.8% |
| December 31, 2024 | $4.26M | -83.1% | -86.4% |
| September 30, 2024 | $31.35M | +18.2% | +34.1% |
| June 30, 2024 | $23.37M | -15.4% | -3.7% |
| March 31, 2024 | $24.26M | -23.8% | -3.8% |
| December 31, 2023 | $25.22M | -14.8% | -4.9% |
- IMPACT BIOMEDICAL INC. showed an increase of +196.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, IMPACT BIOMEDICAL INC.’s stockholders equity has declined by 68.4% (from $39.92 million to $12.61 million).
- The most recent figure is from IMPACT BIOMEDICAL INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: